LEADER 01891oam  2200433   450 
001 9910707684603321
005 20160916093614.0
035   $a(CKB)5470000002465689
035   $a(OCoLC)944264387
035   $a(EXLCZ)995470000002465689
100   $a20160310d2014      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aMedicare program integrity, CMS pursues many practices to address prescription drug fraud, waste, and abuse : report to the Chairman, Subcommittee on Health, Committee on Ways and Means, House of Representatives
210  1$a[Washington, D.C.] :$cUnited States Government Accountability Office,$d2014.
215   $a1 online resource (ii, 34 pages) $ccolor illustrations
300   $aTitle from title screen (viewed on September 15, 2016).
300   $a"October 2014."
300   $a"GAO-15-66."
320   $aIncludes bibliographical references.
517   $aMedicare program integrity, CMS pursues many practices to address prescription drug fraud, waste, and abuse 
606   $aMedicare fraud$xPrevention
606   $aMedication abuse$zUnited States$xPrevention
606   $aWaste in government spending$zUnited States
615  0$aMedicare fraud$xPrevention.
615  0$aMedication abuse$xPrevention.
615  0$aWaste in government spending
712 02$aUnited States.$bCongress.$bHouse.$bCommittee on Ways and Means.$bSubcommittee on Health,
801  0$bVVK
801  1$bVVK
801  2$bOCLCQ
801  2$bGPO
906   $aBOOK
912   $a9910707684603321
996   $aMedicare program integrity, CMS pursues many practices to address prescription drug fraud, waste, and abuse : report to the Chairman, Subcommittee on Health, Committee on Ways and Means, House of Representatives$93357563
997   $aUNINA